In our immunohistochemical analysis, including 411 normal and 349 BC cases, we detected FAM83A overexpression in BC as compared with normal breasts and an equal expression of FAM83A among ER, PR, and HER2 + BC. This evidence concerns the gene ERBB2 and breast cancer.